Skandinaviska Enskilda Banken AB publ bought a new position in shares of Mylan NV (NASDAQ:MYL) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 354,558 shares of the company’s stock, valued at approximately $12,977,000. Skandinaviska Enskilda Banken AB publ owned about 0.07% of Mylan as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in MYL. Allianz Asset Management GmbH lifted its holdings in Mylan by 120.8% during the 1st quarter. Allianz Asset Management GmbH now owns 599,969 shares of the company’s stock worth $24,701,000 after buying an additional 328,258 shares during the last quarter. CENTRAL TRUST Co lifted its holdings in shares of Mylan by 1,057.8% in the 2nd quarter. CENTRAL TRUST Co now owns 5,210 shares of the company’s stock worth $188,000 after purchasing an additional 4,760 shares during the last quarter. Xact Kapitalforvaltning AB lifted its holdings in shares of Mylan by 8.3% in the 2nd quarter. Xact Kapitalforvaltning AB now owns 91,774 shares of the company’s stock worth $3,317,000 after purchasing an additional 7,013 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its holdings in shares of Mylan by 9.8% in the 2nd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 144,244 shares of the company’s stock worth $5,213,000 after purchasing an additional 12,815 shares during the last quarter. Finally, Regent Investment Management LLC lifted its holdings in shares of Mylan by 13.6% in the 2nd quarter. Regent Investment Management LLC now owns 76,905 shares of the company’s stock worth $2,779,000 after purchasing an additional 9,235 shares during the last quarter. 82.99% of the stock is currently owned by institutional investors.
Shares of Mylan stock opened at $36.95 on Friday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.77 and a current ratio of 1.26. The firm has a market cap of $18.84 billion, a price-to-earnings ratio of 8.10, a price-to-earnings-growth ratio of 1.20 and a beta of 1.53. Mylan NV has a 1-year low of $30.33 and a 1-year high of $47.82.
Mylan (NASDAQ:MYL) last announced its earnings results on Monday, November 5th. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.06. The firm had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.91 billion. Mylan had a return on equity of 19.39% and a net margin of 4.71%. The firm’s revenue for the quarter was down 4.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.10 EPS. On average, research analysts forecast that Mylan NV will post 4.68 EPS for the current fiscal year.
Several brokerages recently issued reports on MYL. ValuEngine raised Mylan from a “strong sell” rating to a “sell” rating in a report on Tuesday. Royal Bank of Canada cut their price target on Mylan from $51.00 to $50.00 and set a “buy” rating on the stock in a report on Tuesday. JPMorgan Chase & Co. set a $45.00 price target on Mylan and gave the stock a “buy” rating in a report on Tuesday. Cowen set a $31.00 price target on Mylan and gave the stock a “hold” rating in a report on Tuesday. Finally, Wells Fargo & Co reissued a “hold” rating on shares of Mylan in a report on Wednesday, July 25th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and thirteen have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $46.87.
COPYRIGHT VIOLATION NOTICE: “354,558 Shares in Mylan NV (MYL) Purchased by Skandinaviska Enskilda Banken AB publ” was reported by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/11/10/354558-shares-in-mylan-nv-myl-purchased-by-skandinaviska-enskilda-banken-ab-publ.html.
Mylan Company Profile
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.
Recommended Story: What is a Call Option?
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan NV (NASDAQ:MYL).
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.